LENZ Therapeutics, Inc. (LENZ) NASDAQ
9.67
+0.32(+3.42%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
9.67
+0.32(+3.42%)
Currency In USD
| Market Cap | 461.01M |
| Enterprise Value | 436.18M |
| P/E Ratio | -3.66 |
| PEG Ratio | 0.11 |
| Price/Sales Ratio | 15.88 |
| Price/Book Ratio | 1.06 |
| Enterprise/Revenue | 14.58 |
| Enterprise/EBITDA | -3.14 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
| Profit Margin | -4.3 |
| Operating Margin | -4.77 |
| Return On Assets | -0.27 |
| Return On Equity | -0.37 |
| Revenue | 19.09M |
| Revenue/Share | 0.61 |
| Gross Profit | 18.67M |
| EBITDA | -91.14M |
| Net Income | -82.13M |
| Diluted EPS | -2.85 |
| Total Cash | 292.35M |
| Total Cash/Share | 9.41 |
| Total Debt | 350,000 |
| Total Debt/Equity | 0 |
| Current Ratio | 13.8 |
| Book Value Per Share | 9.15 |
| 52-Week Change | -50.41 |
| 52-Week High | 50.4 |
| 52-Week Low | 8.25 |
| Moving Average 50 Days | 13.08 |
| Moving Average 200 Days | 26.82 |
| Average Volume | 1.12M |
| Shares Outstanding | 31.35M |
| % Held by Institutions | 122.88 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:7 |
| Last Split Date | March 22, 2024 |